Skip to content

Released May 10, 2013, after the close

10-Q filed May 10, 2013, 40 days after period end · 0001144204-13-027924

Q1 2013 · 10-Q
Revenue—
Net Income-$3.72MN/M vs Q1 2012N/M vs Q4 2012
EPS Diluted-$0.22N/M vs Q1 2012N/M vs Q4 2012
Operating Income-$3,768,968N/M
Operating Cash Flow-$4,370,119N/M
Free Cash Flowderived-$4,370,119—

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ1 2013Q1 2012Q1 2011
Net Income-$3.72M-$8.17M-$2.72M
EPS Diluted-$0.22-$0.66-$0.38

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Assembly Biosciences, Inc. · CIK 1426800 · Engraved from SEC EDGAR